MicroPort Endovascular MedTech Ltd Capital Reinvestment Ratio
MicroPort Endovascular MedTech Ltd capital reinvestment ratio. MicroPort Endovascular MedTech Ltd (688016) has a Capital Reinvestment Ratio of 1.84x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥46.79 Million) in capital expenditures (CN¥86.03 Million). Check 688016 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of MicroPort Endovascular MedTech Ltd (2016–2025)
Capital reinvestment ratio of MicroPort Endovascular MedTech Ltd from 2016 to 2025. This chart tracks MicroPort Endovascular MedTech Ltd's Capital Reinvestment Ratio across 10 annual periods. Also explore 688016 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
MicroPort Endovascular MedTech Ltd Capital Reinvestment Ratio by Year (2016–2025)
MicroPort Endovascular MedTech Ltd capital reinvestment ratio by year from 2016 to 2025. For the full cash flow conversion analysis, see 688016 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.53x | CN¥573.06 Million | CN¥303.03 Million | ▼ -7.1% |
| 2024 | 0.57x | CN¥373.60 Million | CN¥212.65 Million | ▲ +70.9% |
| 2023 | 0.33x | CN¥571.22 Million | CN¥190.26 Million | ▼ -62.2% |
| 2022 | 0.88x | CN¥333.76 Million | CN¥293.98 Million | ▲ +195.2% |
| 2021 | 0.30x | CN¥300.25 Million | CN¥89.58 Million | ▲ +147.4% |
| 2020 | 0.12x | CN¥217.44 Million | CN¥26.22 Million | ▼ -18.7% |
| 2019 | 0.15x | CN¥143.20 Million | CN¥21.24 Million | ▼ -36.4% |
| 2018 | 0.23x | CN¥106.85 Million | CN¥24.90 Million | ▼ -42.7% |
| 2017 | 0.41x | CN¥69.36 Million | CN¥28.23 Million | ▼ -61.4% |
| 2016 | 1.06x | CN¥30.13 Million | CN¥31.81 Million | — |